US 9415109
Stable non-aggregating nucleic acid lipid particle formulations
granted A61KA61K47/10A61K47/18
Quick answer
US patent 9415109 (Stable non-aggregating nucleic acid lipid particle formulations) held by Alnylam Pharmaceuticals, Inc. expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61K, A61K47/10, A61K47/18, A61K47/26, A61K47/6911